What is the evidence supporting the use of SGLT2 inhibitors in preventing calcium-based renal calculi?
Year: 2026
Type: article
Abstract: There is direct evidence supporting the use of SGLT2 inhibitors in reducing the risk of nephrolithiasis, including calcium-based stones, primarily driven by their physiological effects on urine composition and flow.
Author: Tripdatabase
Language: English
Subfield: Urology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7225797262
FWCI:
Cites:
Cited by:
Related to: